Cytokinetics Granted Orphan Drug Designation for CK-3773274 for the Treatment of Hypertrophic Cardiomyopathy

NEXT STORY
Turning Point Therapeutics Announces 2021 Milestone Targets
PREV STORY
Travere Therapeutics Provides Corporate Update and 2021 Outlook
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Changes to the Roche Corporate Executive Committee

Basel, 10 December 2018 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that ...

author_avatar
NASDAQ Market News

New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Annual Meeting 2019

author_avatar
NASDAQ Market News

ORIC Pharmaceuticals Announces Presentation of Preclinical Data on Glucocorticoid Receptor Antagonist Overcoming Resistance to an Androgen Receptor Degrader at the 32nd EORTC-NCI-AACR Symposium 2020

author_avatar
NASDAQ Market News